Market Closed -
Other stock markets
|
Pre-market 13:54:27 | |||
1.08 USD | +9.02% | 1.08 | 0.00% |
04-26 | Foreign automakers eager for Chinese partners at Beijing auto show | RE |
04-25 | Battle for 'tech luxury' in China as EVs get smarter - and cheaper | RE |
Business Summary
Number of employees: 233
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Microbiome Therapeutics
100.0
%
| 7 | 100.0 % | 126 | 100.0 % | +1,672.24% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 7 | 100.0 % | 126 | 100.0 % | +1,672.24% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Eric Shaff
CEO | Chief Executive Officer | 48 | 31/10/14 |
David Ege
CTO | Chief Tech/Sci/R&D Officer | 50 | 21/10/20 |
Chief Tech/Sci/R&D Officer | - | 30/04/15 | |
Kelly M. Brady
CTO | Chief Tech/Sci/R&D Officer | - | 31/05/18 |
Marcus Chapman
COO | Chief Operating Officer | 53 | 28/02/15 |
Lisa von Moltke
CTO | Chief Tech/Sci/R&D Officer | 65 | 29/02/20 |
Barbara McGovern
CTO | Chief Tech/Sci/R&D Officer | - | 31/03/15 |
Matthew Henn
CTO | Chief Tech/Sci/R&D Officer | 49 | 31/05/12 |
Carlo Tanzi
IRC | Investor Relations Contact | - | 30/09/15 |
Teresa Young
PRN | Corporate Officer/Principal | 57 | 28/06/20 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Dennis Ausiello
BRD | Director/Board Member | 78 | 31/03/15 |
Director/Board Member | 68 | 03/01/23 | |
Richard Kender
BRD | Director/Board Member | 68 | 05/10/14 |
Kurt Graves
BRD | Director/Board Member | 56 | 31/10/15 |
Paul Biondi
BRD | Director/Board Member | 54 | 19/03/20 |
Eric Shaff
CEO | Chief Executive Officer | 48 | 31/10/14 |
Willard Dere
BRD | Director/Board Member | 70 | 10/07/17 |
Stephen Berenson
CHM | Chairman | 63 | 04/08/19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 151,009,462 | 142,384,021 ( 94.29 %) | 0 | 94.29 % |
Company contact information
Seres Therapeutics, Inc.
200 Sidney Street 4th floor
02139, Cambridge
+617 945 9626
http://www.serestherapeutics.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.86% | 163M | |
-1.17% | 104B | |
+2.87% | 97.47B | |
+4.98% | 22.25B | |
-14.77% | 21.68B | |
-8.84% | 18.2B | |
-39.98% | 17.02B | |
-13.21% | 16.36B | |
+8.55% | 14.39B | |
+35.75% | 12.37B |
- Stock Market
- Equities
- MCRB Stock
- Company Seres Therapeutics, Inc.